Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.

about

Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.

Item

http://www.wikidata.org/entity/Q38811080

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Calcipotriene and betamethason ...... treatment of plaque psoriasis.

@en

type

Item

label

Calcipotriene and betamethason ...... treatment of plaque psoriasis.

@en

prefLabel

Calcipotriene and betamethason ...... treatment of plaque psoriasis.

@en

P1476

Calcipotriene and betamethason ...... treatment of plaque psoriasis.

@en

P2093

Dane Hill

http://www.w3.org/2001/XMLSchema#string

Kevin C Kin

http://www.w3.org/2001/XMLSchema#string

Steven R Feldman

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology of psoriasis: a systematic review of incidence and prevalence

Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy

A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.

Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age

Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.

Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys.

An Applicator Delivery System for Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Topical Suspension (Gel): Innovating Psoriasis Vulgaris Treatment Through Patient Collaboration

Mechanisms of action of topical corticosteroids in psoriasis

P304

789-797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17512433.2016.1179574

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27089906

http://www.w3.org/2001/XMLSchema#string